Skip over navigation

Article Detail - JE Part B

Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R2 - Effective January 01, 2023

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI and Territories), and 01312 (NV).

Effective Date: January 01, 2023

Summary of Article Changes: Under CPT/HCPCS Codes Group 1: Codes the description was revised for 81450. Under CPT/HCPCS Codes Group 4: Codes the description was revised for 81450. This is due to the 2023 Annual/Q1 CPT/HCPCS Code Update and is effective for dates of services on or after 1/1/2023.

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

            Last Updated Mon, 30 Jan 2023 16:04:17 +0000